
TPG-backed Pathology Asia invests Australia's Safe Work

TPG Capital Asia’s Pathology Asia platform has continued a regional roll-up strategy with an investment of undisclosed size in a minority stake in Australian drug testing specialist Safe Work Laboratories.
It follows the acquisition in July last year of a portfolio of 39 pathology laboratories across Singapore, Malaysia, and Vietnam from Australian hospital operator Healthscope for A$279 million ($200 million)....
Latest News
Prosus leads $30m Series C for India agtech start-up
Prosus Ventures, formerly a VC arm of South African media conglomerate Naspers, has led a $30 million Series C round for Indian agricultural technology provider DeHaat.
Fund focus: Endiya sees India’s early-stage upside
Having scaled up in fund size to $75 million for its second vintage, Endiya Partners is looking for opportunities in an increasingly attractive yet competitive Indian start-up ecosystem
Monument Group recruits Japan representative
Placement agent Monument Group has appointed Hiroshi Nishimuro, formerly of Morgan Stanley, as its Japan representative to lead fundraising efforts and manage GP relationships in the country.
Pathway promotes head of Hong Kong office
Simon Lau, who has led the Asian operations at fund-of-funds Pathway Capital Management since 2012, has been promoted to managing director.